Delivery Order SPE2DB24D8002-SPE2DB25FJMRM
Award Date
11/6/24
Potential Completion Date
11/7/24
Potential Value
$5.3K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $11,094.61 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Jardiance 25 mg tablets. This award is part of Dakota Drug's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, valued at $999,999,999.00, which allows the company to provide a wide range of pharmaceutical products, medical supplies, and healthcare equipment to...
The U.S. government's Defense Logistics Agency (DLA) awarded a delivery order contract valued at $2,204.90 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of Jardiance 10 mg tablets. This contract, which has a performance period ending on May 10, 2023, is part of the DLA Troop Support Medical's ECAT Generation V Program, a significant Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00 that allows Dakota Drug, Inc. to supply a wide...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 4,565,231,498 units of Jardiance 10 MG Tablet 90s medication. The contract has a ceiling value of $3,643.63 and a period of performance through July 24, 2024. This order is part of Dakota Drug's larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $4,703.89 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product, with a period of performance through November 25, 2024. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. The IDC...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide 4,566,188 units of the pharmaceutical product JARDIANCE 10 MG TABLET 90S. The contract, valued at $10,284.01, has an ultimate completion date of October 24, 2024. This award is part of Dakota Drug's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,411.33 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of JARDIANCE 25 MG TABLET 30S. This award is part of the DLA Troop Support Medical's ECAT Generation V Program, a major indefinite delivery contract (IDC) valued at $999,999,999.00 that allows Dakota Drug, Inc. to provide a wide range of pharmaceutical products, medical supplies, and healthcare equipment...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide 90 tablets of the prescription medication Jardiance 10 mg. The contract has a ceiling value of $4,835.60 and a performance period that runs through October 17, 2024. The award is not associated with a set-aside program. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide Jardiance 10 mg tablets. The contract, valued at $9,269.99, has an ultimate completion date of August 6, 2024. This award is associated with Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, which allows the company to supply a range of pharmaceutical products, medical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $6,065.59 to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of 4565768026 - JARDIANCE 10 MG TABLET 90S, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Dakota Drug, Inc. holds with the DLA Troop Support Medical's ECAT...
This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $5,915.31 firm fixed-price contract is for the delivery of Jardiance 10 mg tablets to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to provide a...